Catalent, Inc. to Present at the Biopharma CEO Investor Forum

Rhea-AI Summary

Catalent, Inc. (NYSE: CTLT) announced that its Chair and CEO, John Chiminski, will present virtually at the Biopharma CEO Investor Forum on June 8, 2021, at 9:45 a.m. ET. The presentation will be available via a live webcast and can be replayed afterward. Catalent is a prominent global provider focused on advanced delivery technologies and manufacturing solutions across various sectors, including drugs and biologics. With over 85 years of experience and more than $3 billion in revenue for fiscal year 2020, Catalent employs over 15,000 staff worldwide.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that John Chiminski, Chair and Chief Executive Officer, will virtually present at the Biopharma CEO Investor Forum at 9:45 a.m. ET on June 8, 2021.

A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500^® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 15,000 people, including over 2,400 scientists and technicians, at more than 45 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: https://www.businesswire.com/news/home/20210604005034/en/

FAQ

What time will Catalent's CEO present at the Biopharma CEO Investor Forum?

John Chiminski will present virtually at 9:45 a.m. ET on June 8, 2021.

Where can I watch the live webcast of Catalent's CEO presentation?

The live webcast will be accessible at http://investor.catalent.com.

What does Catalent, Inc. specialize in?

Catalent specializes in advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, and cell and gene therapies.

How many employees does Catalent, Inc. have?

Catalent employs over 15,000 people globally.

What was Catalent's revenue for fiscal year 2020?

Catalent generated over $3 billion in revenue for fiscal year 2020.